Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02132533 · ClinicalTrials.gov registry record · Phase 3
Nifedipine for Acute Tocolysis of Preterm Labor
A Phase 3 study of Preterm Labor, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT02132533: Completed Phase 3 study of Preterm Labor, sponsored by University of Texas Southwestern Medical Center.
NCT02132533 is a Phase 3 study of Preterm Labor that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 88 participants, below the 6,072-participant average among 8 other Preterm Labor trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02132533, a Phase 3 study of Preterm Labor, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if nifedipine treatment of women in preterm labor receiving corticosteroids results in postponement of delivery when compared to placebo.
Conditions Studied
Interventions
- DRUG Placebo
- OTHER Usual care
- DRUG Nifedipine
Study Locations (1)
Texas
- Parkland Memorial Hospital - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2014-05-05 |
| Est. Completion | 2018-10-29 |
| Phase | Phase 3 |
What the finished NCT02132533 record still lists
NCT02132533 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 6,072-participant average among 8 other Preterm Labor trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Preterm Labor appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02132533 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02132533 about?
NCT02132533 is a clinical study titled "Nifedipine for Acute Tocolysis of Preterm Labor". The purpose of this study is to determine if nifedipine treatment of women in preterm labor receiving corticosteroids results in postponement of delivery when compared to placebo.
What is the current status of trial NCT02132533?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 88 participants. The study started on 2014-05-05. Estimated completion is 2018-10-29.
What conditions does trial NCT02132533 study?
This clinical trial studies the following conditions: Preterm Labor.
What interventions are being tested in trial NCT02132533?
The interventions under investigation include: Placebo (DRUG), Usual care (OTHER), Nifedipine (DRUG).
Who is sponsoring clinical trial NCT02132533?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02132533 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preterm Labor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02132533's enrollment target sits among peer trials
88 7th of 8 higher than 2 of 8 other Preterm Labor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preterm Labor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Maternal Stress on Human Milk and Infant Outcomes
RECRUITING · NA
-
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
RECRUITING · Phase 4
-
Prospective Data Bank Creation to Study Vaginal Conditions
RECRUITING
-
Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs
ACTIVE NOT RECRUITING · NA
-
MIRACLE of LIFE Study
ACTIVE NOT RECRUITING
-
Omega-3 Fatty Acids for Smoking Cessation in Pregnancy
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI